A proof of concept for structure-based vaccine design targeting RSV in humans

Science
02 August 2019 Vol 365, Issue 6452
http://www.sciencemag.org/current.dtl
Special Issue – CRISPR in China

 

Reports
A proof of concept for structure-based vaccine design targeting RSV in humans
By Michelle C. Crank, Tracy J. Ruckwardt, Man Chen, Kaitlyn M. Morabito, Emily Phung, Pamela J. Costner, LaSonji A. Holman, Somia P. Hickman, Nina M. Berkowitz, Ingelise J. Gordon, Galina V. Yamshchikov, Martin R. Gaudinski, Azad Kumar, Lauren A. Chang, Syed M. Moin, Juliane P. Hill, Anthony T. DiPiazza, Richard M. Schwartz, Lisa Kueltzo, Jonathan W. Cooper, Peifeng Chen, Judith A. Stein, Kevin Carlton, Jason G. Gall, Martha C. Nason, Peter D. Kwong, Grace L. Chen, John R. Mascola, Jason S. McLellan, Julie E. Ledgerwood, Barney S. Graham, the VRC 317 Study Team
Science02 Aug 2019 : 505-509 Restricted Access
Human immunogenicity data confirms that a designed respiratory syncytial virus antigen elicits effective neutralizing antibodies.